메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
황성은 (서울대학교(연건캠퍼스)) 손효신 (서울대학교병원) 김만호 (서울대학교) 이상건 (서울대학교) 정기영 (서울대학교)
저널정보
대한신경과학회 Journal of Clinical Neurology Journal of Clinical Neurology 제18권 제1호
발행연도
2022.1
수록면
65 - 70 (6page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
Background and Purpose Zolpidem is one of the most common hypnotics prescribed to treat insomnia worldwide. However, there are numerous reports of a positive association be tween zolpidem and mortality, including an association with increased cancer-specific mor tality found in a Taiwanese cohort study. This study aimed to determine the association be tween zolpidem use and brain-cancer-specific mortality in patients with brain cancer. Methods This population-based, retrospective cohort study analyzed data in the National Health Insurance Service database. All incident cases of brain cancer at an age of ≥18 years at the time of brain cancer diagnosis over a 15-year period (2003?2017) were included. A mul tivariate Cox regression analysis after adjustment for covariables was performed to evaluate the associations of zolpidem exposure with brain-cancer-specific and all-cause mortality. Results This study identified 38,037 incident cases of brain cancer, among whom 11,823 (31.1%) patients were exposed to zolpidem. In the multivariate Cox regression model, the brain-cancer-specific mortality rate was significantly higher in patients who were prescribed zolpidem than in those with no zolpidem prescription (adjusted hazard ratio [HR]=1.14, 95% confidence interval [CI]=1.08?1.21, p<0.001). Zolpidem exposure was significantly associat ed with increased brain-cancer-specific mortality after adjustment in younger adults (age 18? 64 years; adjusted HR=1.37, 95% CI=1.27?1.49) but not in older adults (age ≥65 years; adjust ed HR=0.94, 95% CI=0.86?1.02). Conclusions Zolpidem exposure was significantly associated with increased brain-cancer specific mortality in patients with brain cancer aged 18?64 years. Further prospective studies are warranted to understand the mechanism underlying the effect of zolpidem on mortality in patients with brain cancer.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0